CD20, Human (Ocaratuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD20, Human (Ocaratuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD20, Human (Ocaratuzumab biosimilar)
CloneOcaratuzumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsNeut, ELISA, IF, IP, FuncS, FCM, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD20 Recombinant Antibody (Ocaratuzumab). Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity Fc RIIIa allotypes.
Immunogenn/a
Other NamesAnti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab, Anti-Human CD20 Recombinant Antibody(Ocaratuzumab), AME-133v, LY2469298, Antibody Drug Analogues, Monoclonal Antibody, YR1285, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1169956-08-4
Catalog #YR1285
Priceplease inquire
Order / More InfoCD20, Human (Ocaratuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.